Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
about
A review of picotamide in the reduction of cardiovascular events in diabetic patientsLong-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors.Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonistThe role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activationAspirin resistance: definition, mechanisms and clinical read-outsThe role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular eventsA review of aspirin resistance; definition, possible mechanisms, detection with platelet function tests, and its clinical outcomesAspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular diseaseAspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphismEffect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factorsEffects of exercise and diet on chronic diseaseTetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release.Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control studyThe relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosisAre isoprostanes a clinical marker for antioxidant drug investigation?Alcohol-induced generation of lipid peroxidation products in humansArsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesionsAdipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Biochemical evidence for a link between elevated levels of homocysteine and lipid peroxidation in vivo.Antioxidants and coronary artery disease.Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injuryGlomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species--ERK/JNK pathways.Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studiesOxidative stress, alpha-tocopherol therapy, and atherosclerosis.Clinical trials of vitamin E in coronary artery disease: is it time to reconsider the low-density lipoprotein oxidation hypothesis?Antioxidant vitamins and their influence in diabetes mellitus.Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trialIntrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats.Circulating Lp-PLA₂ activity correlates with oxidative stress and cytokines in overweight/obese postmenopausal women not using hormone replacement therapyThe postprandial effects of dietary antioxidants in humans.IPF2alpha-I: an index of lipid peroxidation in humansImpact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.Isoprostanes and other markers of peroxidation in atherosclerosis.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Lipoprotein-associated proteins involved in platelet signaling.Current analytical methods for the detection of dityrosine, a biomarker of oxidative stress, in biological samples.Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine
P2860
Q24681255-8DA56B2D-79CA-4D25-B5CA-31C4A421C846Q24794281-7FB07336-E654-4BB1-9C25-688A102E8515Q28167658-B5601F29-AAC6-4917-8D30-AC12AA45CEFFQ28189964-D0BDBEBE-6FF4-433F-99DD-5E17B6180B0DQ28199030-628FED4C-0AB9-4817-87FC-E27F2F665DDCQ28200575-4BB5F6F9-195E-4DF3-AD78-0150BE3A2585Q28213348-FBFA2EA4-5FCF-4EA9-9BED-C67515C70BF3Q28217948-B7766853-E84F-426F-A639-0A95ABBBF46CQ28217995-4AE3D20F-7521-4B4B-A830-BB402A1CB012Q28287127-BC158D22-F1F6-448A-ACEF-FA1A239077CDQ28297798-A98F1CDB-24DF-431C-9C61-4DAF7F1B190EQ30813656-71E6937A-13FB-4C3D-8CC5-C35A29818936Q31452265-22EEA2D7-3A64-4905-895A-A4354B9FA7BCQ33205493-7034E841-A4BE-4A90-AB34-F6E2AA86DF43Q33601191-A7DB8A66-FCC1-4C75-BD97-D6857EAAA64CQ33835675-6C4A6DAB-ED9E-4753-8A74-3B45C122B129Q33841791-B0303FA1-640F-4715-B3BE-26A666C0AB4BQ33853653-22FE94C4-A07F-402B-9B19-9A95E6CD9A6BQ33856080-A0646A1C-E715-4777-B079-61AAEAF327A3Q33864168-049FBEC8-22F3-4600-AD9A-419C0A39E4CDQ34002877-298B3828-EC38-43E4-93D2-71F0A5BC589CQ34107196-0A1F3F21-867E-4197-AB27-9EE0A259A51AQ34107270-BECC4BEE-180E-41E9-9A5F-752C9385F509Q34146989-8F2099FE-1327-4FC7-8C47-C2C14450BCC3Q34283151-0E55D169-ABE7-4F17-9CCA-3F04356C9476Q34361581-A2A75B3B-423C-40C0-A120-4F815CB13024Q34774225-0ABF1A06-D4B8-4B5B-BD7C-85A92943B226Q35062312-1240BD52-3937-4CAE-AF7C-8A0433DE951EQ35087554-C00194BE-A5EF-40ED-BF19-61078D693397Q35120244-C486D3B3-B320-47B0-AE7C-D06C994168A1Q35161497-817BC901-1259-4738-919E-D6A45707EE25Q35267751-71D0277E-FCDD-4B38-AD59-EECF5098C83FQ35549913-233A5F4F-301B-4860-91B7-E4EAE98D9601Q36001536-957CEB7E-317D-4F07-AF02-6A31036035B8Q36024430-254D299A-BFAE-4490-A741-72CE9F8BB8A3Q36317986-D63C9D54-330C-4FE9-AA82-012CADA60544Q36359500-FD5EE136-8344-4E4F-852D-3BA89C0AF1DCQ36551313-47E51F64-B3A5-476F-882F-8A93EE4D25DDQ36613648-3BAE2914-C5E0-4C50-880A-B8BA30982788Q36674399-9841B877-C99D-42CE-B0A7-5C4DF7B45A54
P2860
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
@en
type
label
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
@en
prefLabel
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
@en
P1476
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
@en
P2093
FitzGerald GA
P304
P356
10.1161/01.ATV.17.11.2309
P407
P577
1997-11-01T00:00:00Z